Ultrastructural morphometric cell evaluation in chronic lymphocytic leukaemias

Area of Science:

• Hematology
• Oncology
• Cell Biology

Background:

• Chronic lymphocytic leukemia (CLL) is a heterogeneous hematologic malignancy.
• Understanding the relationship between clinical presentation and cellular characteristics is crucial for prognosis.
• Previous studies have focused on qualitative morphology, with limited ultrastructural morphometric data.

Purpose of the Study:

• To investigate the correlation between clinical staging and ultrastructural morphometric features of leukaemic cells in CLL.
• To determine if quantitative cellular differences exist across different clinical stages of CLL.
• To explore the potential of ultrastructural morphometry as a biomarker for CLL clinical status.

Main Methods:

• The study analyzed 12 cases of chronic lymphocytic leukemia.
• Qualitative morphological assessment of leukaemic cells was performed.
• Ultrastructural morphometric analysis focused on the volume fractions of nuclear and cytoplasmic components.
• Cases were categorized into clinical groups (0, I, II) for comparison.

Main Results:

• No qualitative morphological differences were detected between leukaemic cells from various clinical groups.
• Ultrastructural morphometric analysis revealed significant differences in cytoplasmic component volume fractions between and within clinical groups.
• While clinical groups were not entirely homogeneous, cases in groups 0, I, and II showed uniformity in nucleus and some cytoplasmic component volume fractions.

Conclusions:

• Ultrastructural morphometry reveals quantitative cellular differences in leukaemic cells that correlate with clinical staging in CLL.
• Leukaemic cell morphology, specifically at the ultrastructural level, may provide insights into the clinical state of the disease.
• Further research using ultrastructural morphometrics could refine prognostic indicators in chronic lymphocytic leukemia.